Contributors to AJMC.com delved into data to share their knowledge about important topics in managed care, and in 2017, these were the top 5 most-read articles they wrote and published on our online managed care network.
Contributors to AJMC.com delved into data to share their knowledge about important topics in managed care, and in 2017, these were the top 5 most-read articles they wrote and published on our online managed care network. Subjects included an examination of private claims data and Lyme disease; new trends in colon cancer screening to increase compliance and improve patient health; interpreting Medicare Shared Services Program data; understanding the new Oncology Care Model; and a coming paradigm shift in managing type 2 diabetes.
If you would like to share your expertise with our online managed care network, please sign up at http://www.ajmc.com/contributor-register.
5. A Window Into Lyme Disease Using Private Claims Data
Cases of Lyme disease surged from 1995 to 2015, and to understand more about the rise, contributor Robin Gelburd, JD, studied FAIR Health’s database of more than 23 billion private healthcare claims. She wrote about the evidence of how the disease is affecting the nation’s rural and urban areas differently, how different age cohorts are impacted, where it is spreading and how it correlates with autoimmune disease.
4. Driving Value With Innovative Approaches to Colon Cancer Screening
Preventive care services, such as cancer screenings, are known to improve outcomes for patients and deliver long-term gains for health plan members. Although national guidelines call for men and women at average risk for colorectal cancer (CRC) to begin screening at age 50, by some estimates, compliance is a mere 38%, as the preparation involved makes it unwelcome for many. Health insurance executive Jim Thompson wrote about newer, less-invasive screening options and the action that is being taken to increase access to these tests.
3. CMS Releases Medicare Shared Savings Program 2016 Results
Travis Broome and Farzad Mostashari, MD, both of healthcare information technology startup firm Aledade, interpreted 2016 CMS data on the Medicare Shared Savings Program. They said the information proves that patience pays off, savings don't have to happen at the expense of quality, and that physician-led accountable care organizations are more successful.
2. Nine Months in: Understanding the Oncology Care Model
Jessica Walradt from the Association of American Medical Colleges and Kelly Price, vice president and chief of healthcare data analytics at DataGen, looked at why practices are participating in the Oncology Care Model, a Medicare pilot that seeks to change the way cancer care is provided and reimbursed in the United States. They also shared the challenges practices have faced over the past 9 months.
1. Type 2 Diabetes: Changing the Paradigm From Management to Reversal
Results from the first 70 days of the Virta Clinic trial suggested the historic dietary approach to management of type 2 diabetes has been all wrong, according to contributor Sarah Hallberg, DO, MS. She wrote that the trial would add to compelling evidence that diabetes can be reversed while reducing medication and without risk, cost, or side effects of bariatric surgery and that reversal can happen in a large percentage of patients, not only in outliers.
Covered Preventive Services at Risk: V-BID Summit Breaks Down the Braidwood v Becerra Case
March 20th 2024For more than a decade, certain high-value preventive care services have been covered at no cost to patients under the Affordable Care Act, but a current legal challenge has the coverage at risk.
Read More
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen
FDA Approves Tislelizumab for Advanced or Metastatic ESCC After Chemotherapy
March 15th 2024The FDA has approved tislelizumab-jsgr (Tevimbra) for single-agent use in adult patients with unresectable or metastatic esophageal squamous cell carcinoma following prior systemic chemotherapy that did not include a PD-1/PD-L1 inhibitor.
Read More
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
Evolution of HDHPs With VBID Components Can Improve Care for Chronic Disease
March 14th 2024Over the course of the last 20 years, high-deductible health plans (HDHPs) have undergone an evolution. Today’s plans, with more high-value services covered predeductible, can improve care for people with chronic diseases, said panelists at the 2024 Value-Based Insurance Design (V-BID) Summit.
Read More
Fragmented Payer System, Vulnerable Supply Chain Among Threats to Accessing Essential Medicines
March 13th 2024During a session of the 2024 V-BID Summit, panelists Stacie Dusetzina, PhD, and Inma Hernandez, PharmD, PhD, discussed how access to essential medications is curtailed not just by the longstanding complexities of insurance design but also by emerging threats such as supply chain weaknesses and cyberattacks.
Read More